| Product Code: ETC9967280 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) HER2 Positive Breast Cancer Treatment Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) HER2 Positive Breast Cancer Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) HER2 Positive Breast Cancer Treatment Market - Industry Life Cycle |
3.4 United States (US) HER2 Positive Breast Cancer Treatment Market - Porter's Five Forces |
3.5 United States (US) HER2 Positive Breast Cancer Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 United States (US) HER2 Positive Breast Cancer Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 United States (US) HER2 Positive Breast Cancer Treatment Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 United States (US) HER2 Positive Breast Cancer Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) HER2 Positive Breast Cancer Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of HER2 positive breast cancer in the US |
4.2.2 Technological advancements in HER2 positive breast cancer treatment options |
4.2.3 Growing investments in research and development for new therapies |
4.3 Market Restraints |
4.3.1 High cost of HER2 positive breast cancer treatments |
4.3.2 Stringent regulatory requirements for approval of new treatments |
4.3.3 Limited access to advanced HER2 positive breast cancer therapies in certain regions |
5 United States (US) HER2 Positive Breast Cancer Treatment Market Trends |
6 United States (US) HER2 Positive Breast Cancer Treatment Market, By Types |
6.1 United States (US) HER2 Positive Breast Cancer Treatment Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Treatment Type, 2021- 2031F |
6.1.3 United States (US) HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.1.4 United States (US) HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.1.5 United States (US) HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.6 United States (US) HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) HER2 Positive Breast Cancer Treatment Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 United States (US) HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 United States (US) HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3 United States (US) HER2 Positive Breast Cancer Treatment Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 United States (US) HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United States (US) HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 United States (US) HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.3.5 United States (US) HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) HER2 Positive Breast Cancer Treatment Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United States (US) HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 United States (US) HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 United States (US) HER2 Positive Breast Cancer Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 United States (US) HER2 Positive Breast Cancer Treatment Market Import-Export Trade Statistics |
7.1 United States (US) HER2 Positive Breast Cancer Treatment Market Export to Major Countries |
7.2 United States (US) HER2 Positive Breast Cancer Treatment Market Imports from Major Countries |
8 United States (US) HER2 Positive Breast Cancer Treatment Market Key Performance Indicators |
8.1 Patient survival rates post-treatment |
8.2 Adoption rates of new HER2 positive breast cancer therapies |
8.3 Rate of clinical trial participation for innovative treatments |
8.4 Patient satisfaction with treatment outcomes |
8.5 Number of oncology centers offering specialized HER2 positive breast cancer care |
9 United States (US) HER2 Positive Breast Cancer Treatment Market - Opportunity Assessment |
9.1 United States (US) HER2 Positive Breast Cancer Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 United States (US) HER2 Positive Breast Cancer Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 United States (US) HER2 Positive Breast Cancer Treatment Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 United States (US) HER2 Positive Breast Cancer Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) HER2 Positive Breast Cancer Treatment Market - Competitive Landscape |
10.1 United States (US) HER2 Positive Breast Cancer Treatment Market Revenue Share, By Companies, 2024 |
10.2 United States (US) HER2 Positive Breast Cancer Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here